Basics |
Climb Bio, Inc. Common Stock
|
IPO Date: |
August 10, 2021 |
Sector: |
Healthcare |
Industry: |
Biotech |
Market Cap: |
$92.58M |
Activated in VL: |
True |
Average Daily Range |
Avg Daily Range: |
$0.28 | 4.47%
|
Avg Daily Range (30 D): |
$0.04 | 3.35%
|
Avg Daily Range (90 D): |
$0.04 | 3.48%
|
Institutional Daily Volume |
Avg Daily Volume: |
.16M |
Avg Daily Volume (30 D): |
.19M |
Avg Daily Volume (90 D): |
.15M |
Trade Size |
Avg Trade Size (Sh.): |
132 |
Avg Trade Size (Sh.) (30 D): |
151 |
Avg Trade Size (Sh.) (90 D): |
129 |
Institutional Trades |
Total Inst.Trades: |
53 |
Avg Inst. Trade: |
$1.97M |
Avg Inst. Trade (30 D): |
$2.68M |
Avg Inst. Trade (90 D): |
$1.62M |
Avg Inst. Trade Volume: |
.4M |
Avg Inst. Trades (Per Day): |
1 |
Market Closing Trades |
Avg Closing Trade: |
$4.19M |
Avg Closing Trade (30 D): |
$2.68M |
Avg Closing Trade (90 D): |
$2.68M |
Avg Closing Volume: |
648.35K |
|
|
Financials |
|
TTM |
FY 2024 |
N/A |
Basic EPS
|
$-.31
|
$-1.53
|
|
Diluted EPS
|
$-.31
|
$-1.53
|
|
Revenue
|
$ M
|
$ M
|
$
|
Gross Profit
|
$
|
$
|
$
|
Net Income / Loss
|
$ -20.78M
|
$ -73.9M
|
$
|
Operating Income / Loss
|
$ -23.02M
|
$ -82.02M
|
$
|
Cost of Revenue
|
$
|
$
|
$
|
Net Cash Flow
|
$ M
|
$ -5.93M
|
$
|
PE Ratio
|
|
|
|
|
|
|